Search - tctmd.com

Displaying 221 - 240 of 325

Sort: Relevancy | Date

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

Presentation TCT 2015

How Did We Manage This Patient?

Presenter: Paul A. Gurbel, Daniel I. Simon, Thomas D. Stuckey

October 12, 2015

Presentation TCT 2015

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Presenter: Paul A. Gurbel, Daniel I. Simon, Thomas D. Stuckey

October 12, 2015

Presentation TCT 2015

Case 2: How Did We Manage This Patient?

Presenter: Paul A. Gurbel, Daniel I. Simon, Michael S. Lee

October 12, 2015

Presentation TCT 2015

Case 2: A Patient With Cardiac Arrest and ST-Segment Elevation

Presenter: Paul A. Gurbel, Daniel I. Simon, Michael S. Lee

October 12, 2015

Presentation TCT 2015

Case 1: How Did We Manage This Patient?

Presenter: Paul A. Gurbel, Daniel I. Simon, Usman Baber

October 12, 2015

Presentation TCT 2015

Case 1: Active Bleeding Soon After DES Implantation

Presenter: Paul A. Gurbel, Daniel I. Simon, Usman Baber

October 12, 2015

Presentation TCT 2015

DAPT Duration Case 2: An Elderly Patient With CKD and Left Main Bifurcation Stenting Postdischarge Course

Presenter: John A. Bittl, Gary L. Schaer, Gennaro Giustino

October 12, 2015

Presentation TCT 2015

DAPT Duration Case 1: An Elderly Patient With CKD and Left Main Bifurcation Stenting In-Hospital Course

Presenter: John A. Bittl, Gary L. Schaer, Gennaro Giustino

October 12, 2015

Presentation TCT 2015

Is Dropping Aspirin the Magic Solution?

Presenter: John A. Bittl, Gary L. Schaer, Pascal Vranckx

October 12, 2015

Presentation TCT 2015

Risk vs Benefit: Can We Determine Which Patients Should Be Treated With Long-term DAPT?

Presenter: John A. Bittl, Gary L. Schaer, Matthew T. Roe

October 12, 2015

Presentation TCT 2015

Does PEGASUS Inform the Debate?

Presenter: John A. Bittl, Gary L. Schaer, Stephen D. Wiviott

October 12, 2015

Presentation TCT 2015

Debate: The Optimal Duration of DAPT After DES Is Less Than 12 Months for Most!

Presenter: John A. Bittl, Gary L. Schaer, Tullio Palmerini

October 12, 2015

Presentation TCT 2015

Debate: The Optimal Duration of DAPT After DES Is More Than 12 Months for Most!

Presenter: John A. Bittl, Gary L. Schaer, Laura Mauri

October 12, 2015

Presentation TCT 2015

South Africa Presents: Current Antiplatelet Therapy

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill, Riaz S Dawood

October 12, 2015

Presentation TCT 2015

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Cangrelor!

Presenter: Eric Boersma, E. Magnus Ohman, Deepak L. Bhatt

October 12, 2015

Presentation TCT 2015

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Prasugrel Is Just as Good!

Presenter: Eric Boersma, E. Magnus Ohman, Giuseppe Biondi-Zoccai

October 12, 2015

Presentation TCT 2015

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Prehospital or Crushed Ticagrelor!

Presenter: Eric Boersma, E. Magnus Ohman, Dimitrios Alexopoulos

October 12, 2015

Advertisement

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Discussion Highlights Merits, Limitations of Small Trials

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

How Did We Manage This Patient?

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Case 2: How Did We Manage This Patient?

Case 2: A Patient With Cardiac Arrest and ST-Segment Elevation

Case 1: How Did We Manage This Patient?

Case 1: Active Bleeding Soon After DES Implantation

DAPT Duration Case 2: An Elderly Patient With CKD and Left Main Bifurcation Stenting Postdischarge Course

DAPT Duration Case 1: An Elderly Patient With CKD and Left Main Bifurcation Stenting In-Hospital Course

Is Dropping Aspirin the Magic Solution?

Risk vs Benefit: Can We Determine Which Patients Should Be Treated With Long-term DAPT?

Does PEGASUS Inform the Debate?

Debate: The Optimal Duration of DAPT After DES Is Less Than 12 Months for Most!

Debate: The Optimal Duration of DAPT After DES Is More Than 12 Months for Most!

South Africa Presents: Current Antiplatelet Therapy

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Cangrelor!

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Prasugrel Is Just as Good!

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Prehospital or Crushed Ticagrelor!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content